Shane Legg, co-founder and Chief AGI Scientist at Google DeepMind, defines levels of artificial general intelligence (AGI) as ...
Drug discovery is a high-risk, high-cost endeavor, with over 90% of candidates failing in clinical development. A significant proportion of these failures stem from unresolved biopharmaceutic ...
Drug discovery is a high-risk, high-cost endeavor, with over 90% of candidates failing in clinical development. A significant proportion of these ...
The 'Algorithm Master,' computer science focuses on complexity analysis and theoretical design. Top colleges per NIRF 2025 ...
Apple’s “App Intents” and Huawei’s “Intelligent Agent Framework” allow the OS to expose app functionalities as discrete ...
AI-driven discovery, EHR-based real-world evidence, and synthetic patient modeling are rapidly reshaping drug repurposing, reducing development timelines, expanding therapeutic applications, and ...
The agenda for the 25 (th) annual Bio-IT World Conference & Expo highlights the latest advancements in agentic AI, generative AI, federated learning, foundation models, robotics, multimodal data ...
Artificial intelligence is reshaping brain modeling. This review introduces a unified framework where AI functions as a surrogate brain by integrating dynamical modeling, inverse problem solving, and ...
The study introduces a three-circle convergence framework, AI, smart functionality and sustainability, demonstrating that the ...
During early development, tissues and organs begin to bloom through the shifting, splitting, and growing of many thousands of ...
Researchers from Marshall University and the University of Missouri have developed G2PDeep, an innovative web-based platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results